financetom
Business
financetom
/
Business
/
Nike's longtime design and innovation chief John Hoke to retire
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike's longtime design and innovation chief John Hoke to retire
May 29, 2025 9:50 AM

(Reuters) -Nike's ( NKE ) chief innovation officer, John Hoke, is retiring, the world's largest sportswear company said on Thursday.

Hoke, who joined Nike ( NKE ) in 1992, has served as the company's chief design officer before being named chief innovation officer in 2023.

Earlier this month, Nike ( NKE ) CEO Elliott Hill, who took the helm in October to lead a turnaround, had made several changes to the senior leadership team, including promoting insider Phil McCartney to be the new chief innovation, design & product officer.

Nike ( NKE ), in March, forecast a steeper than expected drop in fourth-quarter revenue, signaling caution as it works to rekindle consumer interest.

Bloomberg News first reported Hoke's retirement earlier on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Reports 4 Years of Sustained Remission in Patients With Ulcerative Colitis
Eli Lilly Reports 4 Years of Sustained Remission in Patients With Ulcerative Colitis
Oct 7, 2025
07:21 AM EDT, 10/07/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that data from its phase 3 open-label extension study showed that its drug Omvoh, or mirikizumab-mrkz, achieved sustained clinical, endoscopic and steroid-free remission over four years in patients with moderate to severely active ulcerative colitis. After four years of treatment, the company said that 78% of...
Canadian retailer Kits Eyecare misses Q3 sales estimates
Canadian retailer Kits Eyecare misses Q3 sales estimates
Oct 7, 2025
Overview * Kits Eyecare ( KTYCF ) Q3 revenue up 25.1% yr/yr to C$52.4 mln, missing estimates * Adjusted EBITDA for Q3 increased to approximately 5.2% of revenue * New customers grew 27.6% yr/yr to about 99,000 Outlook * Company did not provide specific guidance for future quarters or year Result Drivers * CUSTOMER GROWTH - New customers increased by...
Shell Collaborates With Indonesia Government to Address Gasoline Supply Issues
Shell Collaborates With Indonesia Government to Address Gasoline Supply Issues
Oct 7, 2025
07:15 AM EDT, 10/07/2025 (MT Newswires) -- Shell (SHEL) is working with the Indonesian government and other stakeholders to restock gasoline at its fuel stations as quickly as possible, Bloomberg reported Tuesday, citing a company spokesperson. The company's retail stations in Indonesia are experiencing gasoline shortages for the second time in less than two months, due to ongoing import restrictions,...
Lexeo Says FDA Open to Application Submission for Accelerated Approval of Friedreich Ataxia Cardiomyopathy Treatment
Lexeo Says FDA Open to Application Submission for Accelerated Approval of Friedreich Ataxia Cardiomyopathy Treatment
Oct 7, 2025
07:23 AM EDT, 10/07/2025 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Tuesday the US Food and Drug Administration has indicated openness to a biologics license application submission for accelerated approval of its LX2006 candidate for the treatment of Friedreich ataxia cardiomyopathy. The submission will include interim clinical data from ongoing phase I/II studies of LX2006 pooled with new...
Copyright 2023-2026 - www.financetom.com All Rights Reserved